Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | April 24, 2024 08:06am

Gainers

  • Immutep (NASDAQ:IMMP) stock increased by 15.5% to $2.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $344.7 million.
  • Syra Health (NASDAQ:SYRA) stock rose 14.96% to $1.14. The market value of their outstanding shares is at $7.4 million.
  • Sage Therapeutics (NASDAQ:SAGE) shares increased by 13.12% to $14.65. The company's market cap stands at $880.5 million.
  • Recursion Pharmaceuticals (NASDAQ:RXRX) shares moved upwards by 12.72% to $8.68. The market value of their outstanding shares is at $2.0 billion.
  • Viracta Therapeutics (NASDAQ:VIRX) stock moved upwards by 12.05% to $0.95. The company's market cap stands at $37.3 million.
  • BioVie (NASDAQ:BIVI) stock moved upwards by 11.87% to $0.55. The company's market cap stands at $30.2 million.

Losers

  • Evotec (NASDAQ:EVO) shares declined by 32.2% to $5.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.8 billion. The company's, Q4 earnings came out today.
  • Innovative Eyewear (NASDAQ:LUCY) stock decreased by 17.29% to $0.21. The market value of their outstanding shares is at $2.7 million.
  • Ovid Therapeutics (NASDAQ:OVID) stock declined by 15.32% to $2.71. The company's market cap stands at $191.6 million.
  • BiomX (AMEX:PHGE) stock decreased by 14.23% to $0.3. The company's market cap stands at $16.4 million.
  • Kiora Pharmaceuticals (NASDAQ:KPRX) stock decreased by 13.84% to $0.5. The market value of their outstanding shares is at $13.1 million.
  • Addex Therapeutics (NASDAQ:ADXN) stock declined by 13.72% to $16.17. The market value of their outstanding shares is at $17.2 million. The company's, Q4 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADXN BIVI EVO IMMP KPRX LUCY OVID PHGE RXRX SAGE SYRA VIRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist